Only last month America's Food and Drug Administration approved a medicine called Xalkori (generically, crizotinib) for patients who have a particular type of non-small-cell lung cancer, the most common form of that disease.
就在上个月美国食品药品管理局批准了一种名为Xalkori(通用名:克里唑蒂尼)的新药上市,用于治疗非小细胞肺癌(最常见的一种肺癌)。

![Human anaplastic lymphoma kinase in complex with crizotinib. PDB 2xp2[6]](/uploads/202501/07/2xp20833.png)